Research never stops

Top Story

Evotec and C4XD enter collaboration to identify pre-clinical development candidates for stress-related addictive disorder programme

Hamburg, Germany - 19 January 2015: Evotec AG today announced a research collaboration with C4X Discovery Holdings plc to optimise Orexin-1 selective inhibitors discovered through C4XD's unique NMR technology.

- read more

Evotec achieves further milestones in TargetAD collaboration with Janssen

Hamburg, Germany - 15 January 2015: Evotec AG today announced the achievement of several small, but very important milestones in its TargetAD collaboration with Janssen Pharmaceuticals, Inc. for the identification and selection of novel targets from Evotec's TargetAD database and for the transition of targets into the drug discovery process.

- read more

Evotec and Padlock Therapeutics announce initial success and extension of long-term collaboration

Hamburg, Germany - 07 January 2015: Evotec AG and Padlock Therapeutics, Inc. announced today that they have successfully completed an initial goal in a programme focused on developing inhibitors of protein-arginine deiminases and have further extended the collaboration that was first signed in January 2014.

- read more
loading weather report
Loading weather report...


Mar 16, 2015 - Discovery Summit 2015

Mar 03, 2015 - Credit Suisse 2015 Healthcare conference

Company Presentation January

Building integrated and high-value drug discovery alliances
2015-01_Evotec_Company presentation_January